Announced by the White House Cancer Moonshot in February, CancerX is a public-private partnership to boost innovation in the fight against cancer. Co-hosted by the Moffitt Cancer Center and Digital Medicine Society (DiMe), alongside the Office for the National Coordinator for Health Information Technology (ONC) and Office of the Assistant Secretary for Health (OASH), it convenes the many diverse stakeholders needed to unleash the power of innovation to reduce the burden of cancer for everyone. To learn more or participate in CancerX’s pre-competitive, evidence-generating efforts, Accelerator cohort, or demonstration projects, sign up today.
To unite a diverse and inclusive community of stakeholders and harness our collective superpowers to rapidly pioneer and equitably deploy innovative solutions that can prevent and cure cancer.
To convene the many stakeholders necessary to create, foster, accelerate, and scale the impact of a community of innovators dedicated to reducing the burden of cancer for all people.
CancerX will ignite innovation in pursuit of the promise of a life without cancer through an integrated, three-pronged approach:
Pre-Competitive Evidence Generation
A rolling series of multi-stakeholder initiatives will develop evidence, best practices, toolkits, and value models to drive the success of the mission.
These implementation projects will pilot novel, mission-aligned approaches to demonstrate their value and sustainability for scale to drive broad adoption.
Through this approach, we will establish best practices, build capacity, and demonstrate the impact of innovation on the life of every person on a cancer journey.
2023-2024 Strategic Approach
In early 2022, President Biden reignited the Cancer Moonshot, setting new national goals to cut the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living with and surviving cancer. In its first year, the reignited Cancer Moonshot announced over 25 new programs, policies, and resources in pursuit of these goals.
In February 2023, to mark the one-year anniversary of the new national goals, the Cancer Cabinet – the expert and interagency body responsible for setting the Cancer Moonshot agenda across government agencies – announced three new actions, including the establishment of CancerX – a public-private partnership (PPP) to act as a national accelerator to boost innovation in the fight against cancer.
Bringing together the elite experience of both digital medicine and oncology, the ONC and OASH are partnering with DiMe and Moffitt Cancer Center to co-host CancerX. The DiMe-Moffitt partnership is well established with a proven track record of success convening multi-stakeholder experts, including government partners, to advance the use of digital solutions to reduce the incidence and burden of cancer for all people.
DECEMBER 2021 MULTI-STAKEHOLDER ROUNDTABLE
MAY 2022 ASCO ABSTRACT
JANUARY 2023 PUBLICATION
Reporting a multi-stakeholder driven roadmap for digital innovation in oncology
MARCH 2023 JOURNAL CLUB
Our Founding Members
In June 2023, CancerX announced 90+ founding members who were the very first leaders to commit to driving the success of CancerX to achieve the goals of the Cancer Moonshot.
Members also include the National Cancer Institute
Work is Already Underway!
Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research.